


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
SLNO
Soleno Therapeutics Inc.
$45.72
Strengths

Upgraded on attractively valued

Expands stock buyback program

Outperform the market

Earnings are forecast to grow
Chart
$68.66 (-33.41%)
$67.67 (-32.44%)
$86.65 (-47.24%)
$49.11 (-6.90%)
SLNO has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

High volatilty

SLNO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
SLNO Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SLNO Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is SLNO current stock price?
What are SLNO stock strengths?
What is SLNO Risk Level?
What is SLNO market cap and volume?
What is SLNO current Stock IQ?
Should I buy SLNO stock right now?
Is SLNO a Strong Buy right now?
What does a 'Strong Buy' rating mean for SLNO?
What does a 'Strong Sell' rating mean for SLNO?
What factors influence SLNO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
SLNO
Soleno Therapeutics Inc.
Current Price
$45.72
Stock Insights
Strengths

Upgraded on attractively valued

Expands stock buyback program

Outperform the market

Earnings are forecast to grow

Chart
$68.66 (-33.41%)
$67.67 (-32.44%)
$86.65 (-47.24%)
$49.11 (-6.90%)
SLNO Analysts Opinion
SLNO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
SLNO Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SLNO Street Sentiment is bullish and have positive views on the near-term outlook
SLNO has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

High volatilty

Average key support and resistance price levels.
SLNO Latest Analysis
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating $75 PT Dismisses Patient Slowdown Concerns. Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the cheap US stocks to buy according to analysts. On November 18 Wolfe Research analyst Kalpit Patel initiated coverage of Soleno Therapeutics with an Outperform rating and $75 price target. The companys shares showed recent weakness in the market due to a sequential slowing in the number of [….]
Fri Nov 21, 2025
Wolfe Research Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform Recommendation. Fintel reports that on November 18 2025 Wolfe Research initiated coverage of Soleno Therapeutics (NasdaqCM:SLNO) with a Outperform recommendation. Analyst Price Forecast Suggests 152.03% Upside
Wed Nov 19, 2025
Commit To Buy Soleno Therapeutics At $30 Earn 20.1% Annualized Using Options. Investors considering a purchase of Soleno Therapeutics Inc (Symbol: SLNO) stock but cautious about paying the going market price of $47.38/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in pa
Tue Nov 18, 2025
Soleno Therapeutics announces entry into $100M accelerated share repurchase agreement.
Tue Nov 11, 2025
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement. REDWOOD CITY Calif. Nov. 11 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics Inc. (Soleno) (NASDAQ: SLNO) a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases announced today that its Board of Directors has authorized a share repurchase and that it has entered into an Accelerated Share Repurchase Agreement (ASR) with Jefferies LLC (Jefferies) to repurchase $100 millio
Tue Nov 11, 2025
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings. We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the worst-performing stocks on Wednesday. Soleno Therapeutics extended its losing streak to a 5th consecutive day on Wednesday slashing 26.59 percent to close at $46.87 apiece as investors appeared to have priced in a strong earnings performance [….]
Thu Nov 6, 2025
Oversold Conditions For Soleno Therapeutics (SLNO). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Nov 5, 2025
Soleno Therapeutics GAAP EPS of $0.47 beats by $0.41 revenue of $66M beats by $17.91M.
Tue Nov 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SLNO Stock trends
SLNO Stock performance
SLNO Stock analysis
SLNO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.